Lineage Cell Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 78.38% vs 32.14% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 103.02% vs 1.97% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.60",
          "val2": "3.70",
          "chgp": "78.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.40",
          "val2": "-3.60",
          "chgp": "-77.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.30",
          "val2": "-26.60",
          "chgp": "104.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.90",
          "val2": "-29.80",
          "chgp": "103.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-990.90%",
          "val2": "-1,028.50%",
          "chgp": "3.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 53.68% vs 6.74% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -240.86% vs 13.49% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.60",
          "val2": "9.50",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-21.10",
          "val2": "-20.90",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-50.60",
          "val2": "2.10",
          "chgp": "-2,509.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-63.40",
          "val2": "-18.60",
          "chgp": "-240.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,496.20%",
          "val2": "-2,261.10%",
          "chgp": "76.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

6.60

3.70

78.38%

Operating Profit (PBDIT) excl Other Income

-6.40

-3.60

-77.78%

Interest

0.00

0.00

Exceptional Items

1.30

-26.60

104.89%

Consolidate Net Profit

0.90

-29.80

103.02%

Operating Profit Margin (Excl OI)

-990.90%

-1,028.50%

3.76%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 78.38% vs 32.14% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 103.02% vs 1.97% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

14.60

9.50

53.68%

Operating Profit (PBDIT) excl Other Income

-21.10

-20.90

-0.96%

Interest

0.00

0.00

Exceptional Items

-50.60

2.10

-2,509.52%

Consolidate Net Profit

-63.40

-18.60

-240.86%

Operating Profit Margin (Excl OI)

-1,496.20%

-2,261.10%

76.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 53.68% vs 6.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -240.86% vs 13.49% in Dec 2024

All Annual Results